Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · IEX Real-Time Price · USD
11.08
-0.73 (-6.18%)
At close: Jun 21, 2024, 4:00 PM
11.07
-0.01 (-0.09%)
After-hours: Jun 21, 2024, 6:18 PM EDT

Phathom Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018
Cash & Equivalents
384.26155.89183.42287.5243.77
Upgrade
Cash & Cash Equivalents
384.26155.89183.42287.5243.77
Upgrade
Cash Growth
146.49%-15.01%-36.20%17.94%27632.08%
Upgrade
Receivables
1.640000
Upgrade
Inventory
9.440000
Upgrade
Other Current Assets
2.14.623.113.8711.84
Upgrade
Total Current Assets
397.43160.51186.53291.37255.6
Upgrade
Property, Plant & Equipment
3.623.492.563.361.4
Upgrade
Other Long-Term Assets
12.790.80.340.380.18
Upgrade
Total Long-Term Assets
16.414.32.913.741.58
Upgrade
Total Assets
413.84164.81189.43295.11257.18
Upgrade
Accounts Payable
12.6105.1516.780.7
Upgrade
Current Debt
0.730.710.497.830.16
Upgrade
Other Current Liabilities
25.4515.5313.2830.922.89
Upgrade
Total Current Liabilities
38.7826.2418.9255.523.75
Upgrade
Long-Term Debt
438.12205.8990.8541.1923.41
Upgrade
Other Long-Term Liabilities
9.77.57.54.132.06
Upgrade
Total Long-Term Liabilities
447.82213.3998.3545.3225.48
Upgrade
Total Liabilities
486.6239.62117.28100.8429.22
Upgrade
Total Debt
438.85206.691.3449.0223.57
Upgrade
Debt Growth
112.42%126.18%86.34%107.94%1108.87%
Upgrade
Retained Earnings
-928.69-727.09-529.37-385.49-256.42
Upgrade
Shareholders' Equity
-72.76-74.8172.16194.27227.96
Upgrade
Net Cash / Debt
-54.59-50.7192.08238.48220.19
Upgrade
Net Cash / Debt Growth
---61.39%8.30%-
Upgrade
Net Cash Per Share
-1.06-1.302.497.1819.37
Upgrade
Working Capital
358.65134.28167.61235.84251.85
Upgrade
Book Value Per Share
-1.42-1.911.955.8520.05
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).